FDA Drug Application (202894) for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE by GLENMARK PHARMS

Back to FDA Applications sponsored by GLENMARK PHARMS

Application Number202894
Product Number001
FormCREAM;TOPICAL
DosageEQ 0.05% BASE;1%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Active IngredientBETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE

Active IngredientCount
List of drugs with Active Ingredient BETAMETHASONE DIPROPIONATE11
List of drugs with Active Ingredient CLOTRIMAZOLE15


Back to FDA Applications sponsored by GLENMARK PHARMS